SODIUM CHLORIDE HYPERTONICITY

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: SODIUM CHLORIDE HYPERTONICITY
Generic name: SODIUM CHLORIDE
Manufacturer: YYBA CORP
Product type: HUMAN OTC DRUG
SPL set ID: 439653b9-99b8-4799-8d67-4a2ada9c6783
SPL ID: 4d79a117-dffc-b6b4-e063-6294a90a2291
Version: 5
Effective date: 2026-03-20
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:38:28

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		SODIUM CHLORIDE HYPERTONICITY	openfda.brand_name
generic name		SODIUM CHLORIDE	openfda.generic_name
manufacturer name		YYBA CORP	openfda.manufacturer_name
ndc	package	73581-708-35	openfda.package_ndc
ndc	product	73581-708	openfda.product_ndc
ndc11	package	73581070835	derived:openfda.package_ndc
rxcui		1298435	openfda.rxcui
spl id		4d79a117-dffc-b6b4-e063-6294a90a2291	id
spl set id		439653b9-99b8-4799-8d67-4a2ada9c6783	set_id
unii		451W47IQ8X	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use except under the advice and supervision of a doctor. When using this product it may cause temporary burning and irritation replace cap after use to avoid contamination, do not touch tip of container to any surface Stop use and ask a doctor if condition worsens or persists for more than 72 hours you experience eye pain, changes in vision, continued redness or irritation of the eye

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.